Full View

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use

GP Fadini, D Losordo, S Dimmeler - Circulation research, 2012 - Am Heart Assoc
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …
被引用次数：766 相关文章

[引用][C] Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

G PAOLO FADINI, D LOSORDO… - Circulation …, 2012 - pascal-francis.inist.fr
Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and
Diagnostic Use CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

G Fadini, D Losordo, S Dimmeler - CIRCULATION RESEARCH, 2012 - research.unipd.it
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …
[HTML] nih.gov

[HTML][HTML] Critical re-evaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use

GP Fadini, D Losordo, S Dimmeler - Circulation Research, 2012 - ncbi.nlm.nih.gov
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials and circulating EPCs levels are considered as biomarkers for …
[PDF] psu.edu

[PDF][PDF] Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

GP Fadini, D Losordo, S Dimmeler - Imaging, 2011 - Citeseer
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use

GP Fadini, D Losordo, S Dimmeler - Circulation research, 2012 - pubmed.ncbi.nlm.nih.gov
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

GP Fadini, D Losordo, S Dimmeler - Circulation Research, 2012 - cir.nii.ac.jp
抄録< jats: p> Diverse subsets of endothelial progenitor cells (EPCs) are used for the
treatment of ischemic diseases in clinical trials, and circulating EPCs levels are considered …

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

GP Fadini, D Losordo, S Dimmeler - Circulation Research, 2012 - europepmc.org
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials and circulating EPCs levels are considered as biomarkers for …

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

GP Fadini, D Losordo, S Dimmeler - Circulation Research, 2012 - europepmc.org
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials and circulating EPCs levels are considered as biomarkers for …

[引用][C] Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use

F GP - Circ Res, 2012 - cir.nii.ac.jp